NCT00116909View on ClinicalTrials.gov

A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

August 31, 2005

Conditions
Locally Recurrent or Metastatic Cancer of the Head and NeckMust Have Failed First-Line Therapy
Interventions
DRUG

OSI 7904L

Trial Locations (4)

11794

Stony Brook University Hospital, Stony Brook

37203

Sarah Cannon Cancer Center, Nashville

37232

The Vanderbilt Cancer Center, Nashville

02115

Dana-Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
lead

OSI Pharmaceuticals

INDUSTRY

NCT00116909 - A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy | Biotech Hunter | Biotech Hunter